PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and Testing
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Lung Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 55 - 80 |
| Updated: | 1/26/2018 |
| Start Date: | July 11, 2014 |
| End Date: | July 2020 |
Promoting Informed Decisions About Lung Cancer Screening: Decision Aid Update and Measures Development
Objectives:
This protocol addresses the first phase of a larger project funded by the Patient-Centered
Outcomes Research Institute to help heavy smokers make informed decisions about lung cancer
screening with low-dose computed tomography (CT). A separate IRB protocol will be submitted
for the larger, comparative study. In this initial development phase, our prototype patient
decision aid will be updated to reflect current guidelines about lung cancer screening. The
updated aid will then be pilot-tested in a new sample of patients. In addition, several of
the study measures will be refined and further developed in preparation for the larger study.
The specific aims of the measures and decision aid development phase of this project are as
follows:
Update the aid to reflect current screening guidelines and refine the aid via cognitive
testing with patients/smokers; and pilot test the updated aid for acceptability with
patients/smokers.
Modify our current measure of lung cancer knowledge, conduct cognitive testing of the new
measure with patients/smokers, and evaluate the reliability of the new measure in a sample
patients/smokers.
This protocol addresses the first phase of a larger project funded by the Patient-Centered
Outcomes Research Institute to help heavy smokers make informed decisions about lung cancer
screening with low-dose computed tomography (CT). A separate IRB protocol will be submitted
for the larger, comparative study. In this initial development phase, our prototype patient
decision aid will be updated to reflect current guidelines about lung cancer screening. The
updated aid will then be pilot-tested in a new sample of patients. In addition, several of
the study measures will be refined and further developed in preparation for the larger study.
The specific aims of the measures and decision aid development phase of this project are as
follows:
Update the aid to reflect current screening guidelines and refine the aid via cognitive
testing with patients/smokers; and pilot test the updated aid for acceptability with
patients/smokers.
Modify our current measure of lung cancer knowledge, conduct cognitive testing of the new
measure with patients/smokers, and evaluate the reliability of the new measure in a sample
patients/smokers.
Cognitive and Pilot Testing:
If you agree to take part in this study, you will take part in an interview with a member of
the research staff. The interviewer will take notes of your responses. First, you will be
asked some questions about you, like your age, sex, race, and education level. Then you will
be asked to look at some educational materials about lung cancer screening. These could be
written information, animations, graphics, videos, or questionnaires. You may be asked
questions about:
- Lung cancer and lung cancer screening
- The length of the materials
- The balance of the information found in the materials
The study interview will take place in person at MD Anderson and will take between 1 and 1 ½
hours.
Your participation on this study will be over once the interview is complete.
This is an investigational study.
Up to 50 participants will be enrolled in this part of the study. All will take part at MD
Anderson, UTMB, the Galveston community, or tobacco-related community events.
Measures Reliability Study:
If you agree to take part in this study, you will complete a questionnaire 2 times. The
questionnaire will ask about:
- Lung cancer
- Lung cancer screening
- Making decisions about screening
- Your age, race, gender, and level of education
You will complete the first questionnaire in person. It will take about 20 minutes to fill
out. Then, about 1 month later, you will be asked to fill out the questionnaire again.
The second time you can come in person, or fill out the questionnaire by mail or telephone.
Your participation will be over when the second questionnaire is complete.
This is an investigational study.
Up to 150 participants will be enrolled in this part of the study. All will take part at MD
Anderson, UTMB, the Galveston community, or tobacco-related community events.
If you agree to take part in this study, you will take part in an interview with a member of
the research staff. The interviewer will take notes of your responses. First, you will be
asked some questions about you, like your age, sex, race, and education level. Then you will
be asked to look at some educational materials about lung cancer screening. These could be
written information, animations, graphics, videos, or questionnaires. You may be asked
questions about:
- Lung cancer and lung cancer screening
- The length of the materials
- The balance of the information found in the materials
The study interview will take place in person at MD Anderson and will take between 1 and 1 ½
hours.
Your participation on this study will be over once the interview is complete.
This is an investigational study.
Up to 50 participants will be enrolled in this part of the study. All will take part at MD
Anderson, UTMB, the Galveston community, or tobacco-related community events.
Measures Reliability Study:
If you agree to take part in this study, you will complete a questionnaire 2 times. The
questionnaire will ask about:
- Lung cancer
- Lung cancer screening
- Making decisions about screening
- Your age, race, gender, and level of education
You will complete the first questionnaire in person. It will take about 20 minutes to fill
out. Then, about 1 month later, you will be asked to fill out the questionnaire again.
The second time you can come in person, or fill out the questionnaire by mail or telephone.
Your participation will be over when the second questionnaire is complete.
This is an investigational study.
Up to 150 participants will be enrolled in this part of the study. All will take part at MD
Anderson, UTMB, the Galveston community, or tobacco-related community events.
Inclusion Criteria:
1. Men and women 55 to 80 years of age.
2. Participants must speak English.
3. Current smoker or quit smoking within the past 15 years.
Exclusion Criteria:
1. History of lung cancer.
We found this trial at
2
sites
1515 Holcombe Blvd
Houston, Texas 77030
Houston, Texas 77030
713-792-2121
University of Texas M.D. Anderson Cancer Center The mission of The University of Texas MD...
Click here to add this to my saved trials
Click here to add this to my saved trials